Post-treatment support for cancer survivors

We partner with hospitals to help them support cancer patients after treatment ends without the need for additional clinical staff.

Cancer survivorship is one of the most underserved phases in healthcare. Millions of patients leave treatment every year with ongoing physical and emotional needs, but most health systems lack the resources to support them at scale.

Our platform enables oncology teams to deliver structured, ongoing survivorship care that improves patient outcomes, captures long-term data, and reduces the cost of care.

Cancer doesn’t end when treatment ends

For millions of survivors, the end of treatment is not the end of the journey. It is often the beginning of a long and unsupported phase marked by side effects, fear of recurrence, emotional distress, and the challenge of rebuilding everyday life.

Today, most cancer survivors lack structured post-treatment support, even though survivorship already represents a massive and growing share of healthcare spend. Survivors are often left to manage recovery on their own, without the guidance, monitoring, or care infrastructure they need to heal well.

The healthcare system is not built for what comes next

Hospitals and oncology teams know survivorship care matters, but most lack the staffing, workflows, or infrastructure to deliver it at scale.

New accreditation requirements are making survivorship care more important, yet traditional models remain difficult to implement. Oncology teams are stretched thin, expertise is limited, and most systems are still relying on care delivery methods that are not sustainable.

The After Cancer helps health systems engage patients after treatment without adding staff

The After Cancer extends the oncology program beyond active treatment through a digital survivorship platform built for long-term patient support.

Patients receive personalized plans, evidence-based protocols, guidance for side effect management, and an AI-powered companion that helps answer questions they have about what they are experiencing physically and emotionally.

Providers get a scalable way to monitor patient progress, track quality-of-life outcomes, and deliver survivorship care without hiring additional clinical staff

The After Cancer delivers better outcomes for patients and better economics for providers.

Early traction shows strong market pull

Since our launch in September 2025, The After Cancer has:

1. Signed first 2 hospital contracts
2. Closed paid partnerships with 10 non-profit organizations
3. Supported 600+ cancer survivors
4. Built a $10M qualified pipeline with health systems, with 19 deals in active negotiations
5. Started generating inbound leads from providers interested in survivorship solutions
6. Engaged hundreds of attendees through our monthly expert insights sessions

This is what early product-market fit looks like: real buyers, real patients, and an engaged community that continues to validate the need for better survivorship care.

Our go-to-market is also being accelerated by regulatory tailwinds in community hospitals, where providers increasingly need survivorship solutions to meet accreditation requirements like the Commission on Cancer. That creates a strong wedge for adoption and a clear path to scaling revenue.

The After Cancer is already being adopted by health systems that want to bring evidence-based survivorship support to their patients in a scalable way. Unlike traditional clinical models, The After Cancer doesn't require hospitals to hire dedicated staff.

A team built to solve this problem

The After Cancer brings together the clinical, operational, and technical expertise needed to build the new model for supporting life after cancer.

Our team includes leaders who have built survivorship programs inside hospitals, scaled healthcare operations, developed data-driven products, and supported cancer patients firsthand. We understand both the complexity of care delivery and what it takes to build products that scale.

This mission is also deeply personal. Several of us have experienced cancer in our own lives as patients or caregivers, which gives us not only the expertise to build this, but the conviction to see it through.

A scalable business model in a large and growing market

The survivorship care gap is widening every year, and so is its expenditure.

Cancer survivorship is one of the fastest-growing and least supported areas in healthcare. The number of survivors continues to rise, but the supply of survivorship care is not keeping pace. That mismatch is creating a growing burden for patients, providers, and the healthcare system as a whole.

As more people live longer after treatment, health systems are under increasing pressure to provide follow-up support, manage long-term outcomes, and do it all with limited staff and resources.

At The After Cancer, we help health systems meet that rising demand through our scalable digital model that improves patient support without requiring additional clinical headcount.

In our current go-to-market strategy, we contract directly with hospitals through subscription agreements, priced on a per-patient per-year basis, with a yearly platform fee. This allows providers to offer survivorship support across their patient population while aligning cost with usage, creating predictable recurring revenue for us and a scalable model for them.

Our revenue projections reflect what we believe is a realistic growth path from the early traction we have already established in the last 6 months. We are nurturing our growing pipeline of health system opportunities, currently valued at $10m ARR. We are on track to close 15 new enterprise contracts throughout 2026, reaching $500K in ARR this year.

Over time, we plan to expand beyond providers into health plans, employers, life insurance, and life sciences. That gives The After Cancer a path to becoming core survivorship infrastructure across the cancer ecosystem.

This round will help us turn early traction into repeatable sales

We are raising $500k to accelerate our growth in the next 6 months. This capital will be spent on product development and commercial growth:

1. Develop features needed by larger hospitals and deepen AI-driven care delivery
2. Convert our sales pipeline to reach $500k ARR by the end of 2026
3. Build a scalable product and sales structure to achieve 10x growth in 2027
4. Support thousands of patients and give back quality of life and joy to our users

Cancer survivorship is one of the largest and most underserved opportunities in healthcare.

The After Cancer is building the platform, infrastructure, and data layer to transform how survivorship care is delivered. We’ve shown early traction, proven demand, and built a strong foundation for growth.

Will you join us in building what comes after cancer?